Omixon is pleased to announce our Symposium at the 2017 ASHI Meeting in San Francisco, CA, which will focus on automated NGS-based HLA typing for bone marrow and solid organ programs and the experiences of existing Holotype HLA users in the United States. Our Guest Speakers are going to share their experience with the audience. Omixon’s CEO, Dr. Peter Meintjes will announce major product innovations and new directions for the company.
Event Holotype HLA: Automated NGS-based HLA Typing for Bone Marrow and Solid Organ Programs
Room Imperial, Hilton San Francisco Union Square
Date Thursday, 14 September, 2017
Time 12:00pm-2:00pm PDT
Room Imperial, Hilton San Francisco Union Square
Date Thursday, 14 September, 2017
Time 12:00pm-2:00pm PDT
Agenda
- Welcome & Introduction
- Presentations by Guest Speakers
- Announcement of Major Product Enhancements by Dr. Peter Meintjes (CEO, Omixon)